Medicines Formulary

Medicines A–Z

M

Drug name	NICE TAs	Comments
Midazolam buccal liquid - buccolam
Midazolam injection		Palliative care only
Midodrine		3rd line after non-pharmacological intervention, 2nd line after pharmacological therapy. Supported with an ESCA.
Midostaurin	TA523 - Midostaurin for untreated acute myeloid leukaemia TA738 - Midostaurin for treating advanced systemic mastocytosis	For hospital use only
Mifamurtide	TA235 - Mifamurtide for the treatment of osteosarcoma	For hospital use only
Mifamurtide injection	TA235 - Mifamurtide for the treatment of osteosarcoma	For hospital use only
Mifepristone (Mifegyne)
Migalastat (Galafold)	HST4 - Migalastat for treating Fabry disease
Miglustat (Zavesca)
Migraleve® pink

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.